We combined neuroimaging and epigenetic measures to assess current PTSD symptoms by measuring overall hippocampal volume and methylation of the glucocorticoid receptor (GR) gene (promoter region). The gene discussed is NR3C1; the disease is post-traumatic stress disorder.